AIIMS
IBB icon

Analyst IMS Investment Management Services’s iShares Biotechnology ETF IBB Stock Holding History

Analyst IMS Investment Management Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Hold
23,207
– – 0.1% 54
2026
Q1 		$3.92M Hold
23,207
– – 0.12% 43
2025
Q4 		$3.92M Hold
23,207
– – 0.11% 42
2025
Q3 		$3.35M Sell
23,207
-10,551
-31% -$1.44M 0.1% 43
2025
Q2 		$4.27M Hold
33,758
– – 0.15% 42
2025
Q1 		$4.32M Hold
33,758
– – 0.17% 41
2024
Q4 		$4.46M Hold
33,758
– – 0.16% 38
2024
Q3 		$4.92M Hold
33,758
– – 0.19% 35
2024
Q2 		$4.63M Hold
33,758
– – 0.19% 32
2024
Q1 		$4.63M Hold
33,758
– – 0.2% 29
2023
Q4 		$4.59M Hold
33,758
– – 0.24% 28
2023
Q3 		$4.15M Hold
33,758
– – 0.26% 26
2023
Q2 		$4.25M Hold
33,758
– – 0.29% 25
2023
Q1 		$4.29M Hold
33,758
– – 0.33% 24
2022
Q4 		$4.43M Hold
33,758
– – 0.38% 24
2022
Q3 		$3.97M Hold
33,758
– – 0.39% 24
2022
Q2 		$3.97M Sell
33,758
-300
-0.9% -$35.6K 0.38% 25
2022
Q1 		$4.44M Sell
34,058
-32
-0.1% -$4.17K 0.39% 27
2021
Q4 		$5.24M Buy
34,090
+32
+0.1% +$4.95K 0.5% 26
2021
Q3 		$5.51M Hold
34,058
– – 0.68% 21
2021
Q2 		$5.57M Buy
34,058
+1,100
+3% +$169K 0.67% 22
2021
Q1 		$4.96M Sell
32,958
-100
-0.3% -$15.9K 0.67% 23
2020
Q4 		$5.01M Hold
33,058
– – 0.84% 20
2020
Q3 		$4.48M Buy
33,058
+2,800
+9% +$380K 0.91% 17
2020
Q2 		$4.14M Buy
30,258
+1,010
+3% +$129K 0.96% 16
2020
Q1 		$3.15M Sell
29,248
-600
-2% -$69.1K 1.01% 15
2019
Q4 		$3.6M Buy
29,848
+4,600
+18% +$513K 0.98% 16
2019
Q3 		$2.53M Sell
25,248
-7,467
-23% -$782K 0.75% 20
2019
Q2 		$3.57M Hold
32,715
– – 1.07% 15
2019
Q1 		$3.66M Buy
32,715
+9,099
+39% +$998K 1.13% 15
2018
Q4 		$2.28M Hold
23,616
– – 0.36% 31
2018
Q3 		$2.88M Hold
23,616
– – 0.46% 21
2018
Q2 		$2.55M Sell
23,616
-294
-1% -$31.4K 0.78% 26
2018
Q1 		$2.55M Sell
23,910
-28,828
-55% -$3.2M 0.81% 28
2017
Q4 		$5.63M Sell
52,738
-50
-0.1% -$5.34K 1.72% 16
2017
Q3 		$5.81M Buy
52,788
+30
+0.1% +$3.21K 1.91% 14
2017
Q2 		$5.45M Buy
52,758
+41,136
+354% +$4.05M 1.94% 16
2017
Q1 		$1.14M Buy
11,622
+1,755
+18% +$168K 0.44% 51
2016
Q4 		$873K Sell
9,867
-225
-2% -$20.5K 0.38% 60
2016
Q3 		$973K Hold
10,092
– – 0.41% 54
2016
Q2 		$866K Buy
10,092
+498
+5% +$44.7K 0.37% 54
2016
Q1 		$834K Sell
9,594
-2,604
-21% -$233K 0.36% 57
2015
Q4 		$1.38M Buy
+12,198
New +$1.32M 0.57% 49

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Analyst IMS Investment Management Services's IBB Position: Q2 2026 in Review

Analyst IMS Investment Management Services held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 23,207 shares worth $4.41M. The position accounts for 0.1% of the portfolio, ranked #54.

Analyst IMS Investment Management Services first reported a position in IBB in Q4 2015 and has held it in 43 quarters since. The position peaked at $5.81M in Q3 2017. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Analyst IMS Investment Management Services held 23,207 shares of iShares Biotechnology ETF worth $4.41M as of Q2 2026.
  • Analyst IMS Investment Management Services left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.1% of Analyst IMS Investment Management Services's portfolio in Q2 2026, its #54 holding.
  • Analyst IMS Investment Management Services first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 43 quarters since.
  • Analyst IMS Investment Management Services's iShares Biotechnology ETF position peaked at $5.81M in Q3 2017.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.